Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [1]
- Immunocytochemistry [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- GTX87506 - Provider product page
- Provider
- GeneTex
- Proper citation
- GeneTex Cat#GTX87506, RRID:AB_10721633
- Product name
- Histone H1 antibody
- Antibody type
- Polyclonal
- Reactivity
- Human, Mouse
- Host
- Rabbit
Submitted references A Novel Mecp2Y120D Knock-in Model Displays Similar Behavioral Traits But Distinct Molecular Features Compared to the Mecp2-Null Mouse Implying Precision Medicine for the Treatment of Rett Syndrome.
FOXM1 Transcription Factor: A New Component of Chronic Myeloid Leukemia Stem Cell Proliferation Advantage.
Brain phosphorylation of MeCP2 at serine 164 is developmentally regulated and globally alters its chromatin association.
14-3-3 Binding and Sumoylation Concur to the Down-Modulation of β-catenin Antagonist chibby 1 in Chronic Myeloid Leukemia.
Gandaglia A, Brivio E, Carli S, Palmieri M, Bedogni F, Stefanelli G, Bergo A, Leva B, Cattaneo C, Pizzamiglio L, Cicerone M, Bianchi V, Kilstrup-Nielsen C, D'Annessa I, Di Marino D, D'Adamo P, Antonucci F, Frasca A, Landsberger N
Molecular neurobiology 2018 Nov 6;
Molecular neurobiology 2018 Nov 6;
FOXM1 Transcription Factor: A New Component of Chronic Myeloid Leukemia Stem Cell Proliferation Advantage.
Mancini M, Castagnetti F, Soverini S, Leo E, De Benedittis C, Gugliotta G, Rosti G, Bavaro L, De Santis S, Monaldi C, Martelli M, Santucci MA, Cavo M, Martinelli G
Journal of cellular biochemistry 2017 Nov;118(11):3968-3975
Journal of cellular biochemistry 2017 Nov;118(11):3968-3975
Brain phosphorylation of MeCP2 at serine 164 is developmentally regulated and globally alters its chromatin association.
Stefanelli G, Gandaglia A, Costa M, Cheema MS, Di Marino D, Barbiero I, Kilstrup-Nielsen C, Ausió J, Landsberger N
Scientific reports 2016 Jun 21;6:28295
Scientific reports 2016 Jun 21;6:28295
14-3-3 Binding and Sumoylation Concur to the Down-Modulation of β-catenin Antagonist chibby 1 in Chronic Myeloid Leukemia.
Mancini M, Leo E, Takemaru K, Campi V, Castagnetti F, Soverini S, De Benedittis C, Rosti G, Cavo M, Santucci MA, Martinelli G
PloS one 2015;10(7):e0131074
PloS one 2015;10(7):e0131074
No comments: Submit comment
Supportive validation
- Submitted by
- GeneTex (provider)
- Main image
- Experimental details
- Western blot analysis of extracts from COLO cells, using Histone H1 (Ab-17) Antibody. The lane on the right is treated with the synthesized peptide.
- Validation comment
- WB
Supportive validation
- Submitted by
- GeneTex (provider)
- Main image
- Experimental details
- Immunofluorescence analysis of HuvEc cells, using Histone H1 Antibody. The picture on the right is treated with the synthesized peptide.
Supportive validation
- Submitted by
- GeneTex (provider)
- Main image
- Experimental details
- Immunohistochemistry analysis of paraffin-embedded human colon carcinoma tissue, using Histone H1 Antibody. The picture on the right is treated with the synthesized peptide.
